Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px
Financing › Details

Agilent–SEVERAL: credit, 201909–202909 public offering $500m net $492.8m Senior Notes 2.75% due Sept 2029

 

Period Period 2019-09-05 ï¿½ 2029-09-01
Products Product investment banking
  Product 2 analytical instrument
     

Agilent Technologies Inc.. (9/5/19). "Press Release: Agilent Technologies Announces Pricing of $500 Million of Senior Notes". Santa Clara, CA.

Agilent Technologies, Inc. (NYSE: A) today announced the pricing of an underwritten, registered public offering of a series of its senior notes in an aggregate principal amount of $500 million. The offering is being conducted under an automatic shelf registration statement on file with the Securities and Exchange Commission. The notes will mature in September 2029 and will bear interest at an annual rate of 2.750 percent. The offering is expected to close on September 16, 2019, subject to customary closing conditions.

The estimated net proceeds of the offering are expected to be approximately $492.8 million. Agilent intends to use the net proceeds from the offering and cash on hand to fund the redemption of its outstanding 5.00% senior notes due 2020.

Barclays Capital Inc., J.P. Morgan Securities LLC and MUFG Securities Americas Inc. are acting as joint book-running managers.

Copies of the prospectus supplement and the accompanying prospectus relating to the offering can be obtained from:

Barclays Capital Inc.
745 Seventh Avenue
New York, NY 10019
Telephone: (888) 603-5847

J.P. Morgan Securities LLC
383 Madison Avenue
New York, NY 10179
Telephone: (212) 834-4533

MUFG Securities Americas Inc.
1221 Avenue of the Americas, 6th Floor
New York, NY 10020-1001
Telephone: (877) 649-6848

Electronic copies of the prospectus supplement and accompanying prospectus are or will be available for free by visiting EDGAR on the Securities and Exchange Commission website at www.sec.gov. This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.


About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions and people provide trusted answers to customers' most challenging questions.


Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the federal securities laws, including with respect to the closing of our senior notes offering and the anticipated use of the net proceeds therefrom. Forward-looking statements are typically identified by words or phrases such as "will," "anticipate," "estimate," "expect," "project," "intend," "plan," "believe," "target," "forecast," and other words and terms of similar meaning. These statements are subject to significant risks and uncertainties, including, without limitation, risks and uncertainties related to economic, market or business conditions and satisfaction of customary closing conditions related to the public offering. No assurance can be given that the securities offering discussed above will be consummated on the terms described or at all. Except as required by law, we expressly disclaim any obligation to publicly revise any forward-looking statements contained in this news release to reflect the occurrence of events after the date of this news release.


Investor Contact

Ankur Dhingra
Agilent Technologies
+1 408 345 8948
ankur_dhingra@agilent.com

   
Record changed: 2019-09-19

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Agilent (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px




» top